ENDRA Life Sciences (NDRA) Invested Capital (2016 - 2021)
Historic Invested Capital for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $13.2 million.
- ENDRA Life Sciences' Invested Capital rose 29448.69% to $13.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.2 million, marking a year-over-year increase of 29448.69%. This contributed to the annual value of $7.8 million for FY2020, which is 6338.7% up from last year.
- According to the latest figures from Q3 2021, ENDRA Life Sciences' Invested Capital is $13.2 million, which was up 29448.69% from $15.0 million recorded in Q2 2021.
- In the past 5 years, ENDRA Life Sciences' Invested Capital registered a high of $17.9 million during Q1 2021, and its lowest value of -$1.4 million during Q1 2017.
- Its 5-year average for Invested Capital is $5.4 million, with a median of $3.8 million in 2019.
- As far as peak fluctuations go, ENDRA Life Sciences' Invested Capital tumbled by 10638.43% in 2018, and later skyrocketed by 143446.68% in 2021.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Invested Capital stood at $5.3 million in 2017, then grew by 18.44% to $6.2 million in 2018, then decreased by 23.81% to $4.8 million in 2019, then surged by 63.39% to $7.8 million in 2020, then soared by 69.14% to $13.2 million in 2021.
- Its last three reported values are $13.2 million in Q3 2021, $15.0 million for Q2 2021, and $17.9 million during Q1 2021.